SEARCH

SEARCH BY CITATION

References

  • Alexander GM, Godwin DW. (2005) Presynaptic inhibition of corticothalamic feedback by metabotropic glutamate receptors. J Neurophysiol 94:163175.
  • Alexander GM, Godwin DW. (2006a) Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy. Epilepsy Res 71:122.
  • Alexander GM, Godwin DW. (2006b) Unique presynaptic and postsynaptic roles of Group II metabotropic glutamate receptors in the modulation of thalamic network activity. Neuroscience 141:501513.
  • Alexander GM, Fisher TL, Godwin DW. (2006) Differential response dynamics of corticothalamic glutamatergic synapses in the lateral geniculate nucleus and thalamic reticular nucleus. Neuroscience 137:367372.
  • Alt A, Weiss B, Ogden AM, Li X, Gleason SD, Calligaro DO, Bleakman D, Witkin JM. (2006) In vitro and in vivo studies in rats with LY293558 suggest AMPA/kainate receptor blockade as a novel potential mechanism for the therapeutic treatment of anxiety disorders. Psychopharmacology 185:240247.
  • Andersson F, Jakobsson J, Low P, Shupliakov O, Brodin L. (2008) Perturbation of syndapin/PACSIN impairs synaptic vesicle recycling evoked by intense stimulation. J Neurosci 28:39253933.
  • Anggono V, Smillie KJ, Graham ME, Valova VA, Cousin MA, Robinson PJ. (2006) Syndapin I is the phosphorylation-regulated dynamin I partner in synaptic vesicle endocytosis. Nat Neurosci 9:752760.
  • Artinian J, Peret A, Marti G, Epsztein J, Crepel V. (2011) Synaptic kainate receptors in interplay with INaP shift the sparse firing of dentate granule cells to a sustained rhythmic mode in temporal lobe epilepsy. J Neurosci 31:1081110818.
  • Atcha Z, Chen WS, Ong AB, Wong FK, Neo A, Browne ER, Witherington J, Pemberton DJ. (2009) Cognitive enhancing effects of ghrelin receptor agonists. Psychopharmacology 206:415427.
  • Avedissian M, Longo BM, Jaqueta CB, Schnabel B, Paiva PB, Mello LE, Briones MR. (2007) Hippocampal gene expression analysis using the ORESTES methodology shows that homer 1a mRNA is upregulated in the acute period of the pilocarpine epilepsy model. Hippocampus 17:130136.
  • Bacci A, Huguenard JR, Prince DA. (2002) Differential modulation of synaptic transmission by neuropeptide Y in rat neocortical neurons. Proc Natl Acad Sci U S A 99:1712517130.
  • Bajjalieh SM, Frantz GD, Weimann JM, McConnell SK, Scheller RH. (1994) Differential expression of synaptic vesicle protein 2 (SV2) isoforms. J Neurosci 14:52235235.
  • Baldelli P, Fassio A, Valtorta F, Benfenati F. (2007) Lack of synapsin I reduces the readily releasable pool of synaptic vesicles at central inhibitory synapses. J Neurosci 27:1352013531.
  • Baraban SC. (1998) Neuropeptide Y and limbic seizures. Rev Neurosci 9:117128.
  • Baraban SC. (2004) Neuropeptide Y and epilepsy: recent progress, prospects and controversies. Neuropeptides 38:261265.
  • Baraban SC, Tallent MK. (2004) Interneuron diversity series: interneuronal neuropeptides – endogenous regulators of neuronal excitability. Trends Neurosci 27:135142.
  • Barad Z, Shevtsova O, Arbuthnott GW, Leitch B. (2012) Selective loss of AMPA receptors at corticothalamic synapses in the epileptic stargazer mouse. Neuroscience 217:1931.
  • Bartfai T, Lu X, Badie-Mahdavi H, Barr AM, Mazarati A, Hua XY, Yaksh T, Haberhauer G, Ceide SC, Trembleau L, Somogyi L, Krock L, Rebek J Jr. (2004) Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests. Proc Natl Acad Sci U S A 101:1047010475.
  • Bartolomei F, Khalil M, Wendling F, Sontheimer A, Regis J, Ranjeva JP, Guye M, Chauvel P. (2005) Entorhinal cortex involvement in human mesial temporal lobe epilepsy: an electrophysiologic and volumetric study. Epilepsia 46:677687.
  • Bennett B, Matagne A, Michel P, Leonard M, Cornet M, Meeus MA, Toublanc N. (2007) Seletracetam (UCB 44212). Neurotherapeutics 4:117122.
  • Beyer B, Deleuze C, Letts VA, Mahaffey CL, Boumil RM, Lew TA, Huguenard JR, Frankel WN. (2008) Absence seizures in C3H/HeJ and knockout mice caused by mutation of the AMPA receptor subunit Gria4. Hum Mol Genet 17:17381749.
  • Biagini G, Torsello A, Marinelli C, Gualtieri F, Vezzali R, Coco S, Bresciani E, Locatelli V. (2011) Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus. Eur J Pharmacol 670:130136.
  • Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS. (2010) Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X). Epilepsy Res 92:89124.
  • Binaschi A, Bregola G, Simonato M. (2003) On the role of somatostatin in seizure control: clues from the hippocampus. Rev Neurosci 14:285301.
  • Binder DK, Croll SD, Gall CM, Scharfman HE. (2001) BDNF and epilepsy: too much of a good thing? Trends Neurosci 24:4753.
  • Bogen IL, Jensen V, Hvalby O, Walaas SI. (2011) Glutamatergic neurotransmission in the synapsin I and II double knock-out mouse. Semin Cell Dev Biol 22:400407.
  • Boison D. (2012) Adenosine dysfunction in epilepsy. Glia 60:12341243.
  • Boumil RM, Letts VA, Roberts MC, Lenz C, Mahaffey CL, Zhang ZW, Moser T, Frankel WN. (2010) A missense mutation in a highly conserved alternate exon of dynamin-1 causes epilepsy in fitful mice. PLoS Genet 6:e1001046.
  • Brain SD, Cox HM. (2006) Neuropeptides and their receptors: innovative science providing novel therapeutic targets. Br J Pharmacol 147(Suppl. 1):S202S211.
  • Brodie MJ, Wroe SJ, Dean AD, Holdich TA, Whitehead J, Stevens JW. (2002) Efficacy and safety of remacemide versus carbamazepine in newly diagnosed epilepsy: comparison by sequential analysis. Epilepsy Behav 3:140146.
  • Bulaj G, Green BR, Lee HK, Robertson CR, White K, Zhang L, Sochanska M, Flynn SP, Scholl EA, Pruess TH, Smith MD, White HS. (2008) Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities. J Med Chem 51:80388047.
  • Cabrele C, Beck-Sickinger AG. (2000) Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family. J Pept Sci 6:97122.
  • Camina JP. (2006) Cell biology of the ghrelin receptor. J Neuroendocrinol 18:6576.
  • Camina JP, Carreira MC, Micic D, Pombo M, Kelestimur F, Dieguez C, Casanueva FF. (2003) Regulation of ghrelin secretion and action. Endocrine 22:512.
  • Cao H, Garcia F, McNiven MA. (1998) Differential distribution of dynamin isoforms in mammalian cells. Mol Biol Cell 9:25952609.
  • Cardoso A, Freitas-da-Costa P, Carvalho LS, Lukoyanov NV. (2010) Seizure-induced changes in neuropeptide Y-containing cortical neurons: potential role for seizure threshold and epileptogenesis. Epilepsy Behav 19:559567.
  • Cavalleri GL, Weale ME, Shianna KV, Singh R, Lynch JM, Grinton B, Szoeke C, Murphy K, Kinirons P, O’Rourke D, Ge D, Depondt C, Claeys KG, Pandolfo M, Gumbs C, Walley N, McNamara J, Mulley JC, Linney KN, Sheffield LJ, Radtke RA, Tate SK, Chissoe SL, Gibson RA, Hosford D, Stanton A, Graves TD, Hanna MG, Eriksson K, Kantanen AM, Kalviainen R, O’Brien TJ, Sander JW, Duncan JS, Scheffer IE, Berkovic SF, Wood NW, Doherty CP, Delanty N, Sisodiya SM, Goldstein DB. (2007) Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case–control study. Lancet Neurol 6:970980.
  • Ceolin L, Bortolotto ZA, Bannister N, Collingridge GL, Lodge D, Volianskis A. (2012) A novel anti-epileptic agent, perampanel, selectively inhibits AMPA receptor-mediated synaptic transmission in the hippocampus. Neurochem Int 61:517522.
  • Chamberlain SE, Jane DE, Jones RS. (2012) Pre- and post-synaptic functions of kainate receptors at glutamate and GABA synapses in the rat entorhinal cortex. Hippocampus 22:555576.
  • Chang WP, Sudhof TC. (2009) SV2 renders primed synaptic vesicles competent for Ca2 +  -induced exocytosis. J Neurosci 29:883897.
  • Chen L, Chetkovich DM, Petralia RS, Sweeney NT, Kawasaki Y, Wenthold RJ, Bredt DS, Nicoll RA. (2000) Stargazin regulates synaptic targeting of AMPA receptors by two distinct mechanisms. Nature 408:936943.
  • Chi P, Greengard P, Ryan TA. (2003) Synaptic vesicle mobilization is regulated by distinct synapsin I phosphorylation pathways at different frequencies. Neuron 38:6978.
  • Chiappalone M, Casagrande S, Tedesco M, Valtorta F, Baldelli P, Martinoia S, Benfenati F. (2009) Opposite changes in glutamatergic and GABAergic transmission underlie the diffuse hyperexcitability of synapsin I-deficient cortical networks. Cereb Cortex 19:14221439.
  • Choi J, Ko J, Park E, Lee JR, Yoon J, Lim S, Kim E. (2002) Phosphorylation of stargazin by protein kinase A regulates its interaction with PSD-95. J Biol Chem 277:1235912363.
  • Clayton EL, Anggono V, Smillie KJ, Chau N, Robinson PJ, Cousin MA. (2009) The phospho-dependent dynamin-syndapin interaction triggers activity-dependent bulk endocytosis of synaptic vesicles. J Neurosci 29:77067717.
  • Collingridge GL, Olsen RW, Peters J, Spedding M. (2009) A nomenclature for ligand-gated ion channels. Neuropharmacology 56:25.
  • Conn PJ, Pin JP. (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37:205237.
  • Contractor A, Swanson GT. (2008) Kainate receptors. In Gereau RW, Swanson GT (Eds) The glutamate receptors. Humana Press, Totowa, NJ, pp. 99158.
  • Contractor A, Mulle C, Swanson GT. (2011) Kainate receptors coming of age: milestones of two decades of research. Trends Neurosci 34:154163.
  • Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, Horvath TL. (2003) The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37:649661.
  • Cramer CL, Stagnitto ML, Knowles MA, Palmer GC. (1994) Kainic acid and 4-aminopyridine seizure models in mice: evaluation of efficacy of anti-epileptic agents and calcium antagonists. Life Sci 54:PL271PL275.
  • Csaba Z, Richichi C, Bernard V, Epelbaum J, Vezzani A, Dournaud P. (2004) Plasticity of somatostatin and somatostatin sst2A receptors in the rat dentate gyrus during kindling epileptogenesis. Eur J Neurosci 19:25312538.
  • Csaba Z, Pirker S, Lelouvier B, Simon A, Videau C, Epelbaum J, Czech T, Baumgartner C, Sperk G, Dournaud P. (2005) Somatostatin receptor type 2 undergoes plastic changes in the human epileptic dentate gyrus. J Neuropathol Exp Neurol 64:956969.
  • Cull-Candy SG, Leszkiewicz DN. (2004) Role of distinct NMDA receptor subtypes at central synapses. Sci STKE 2004:re16.
  • Custer KL, Austin NS, Sullivan JM, Bajjalieh SM. (2006) Synaptic vesicle protein 2 enhances release probability at quiescent synapses. J Neurosci 26:13031313.
  • De Smedt T, Raedt R, Vonck K, Boon P. (2007) Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug. CNS Drug Rev 13:5778.
  • Dev KK, Nishimune A, Henley JM, Nakanishi S. (1999) The protein kinase C alpha binding protein PICK1 interacts with short but not long form alternative splice variants of AMPA receptor subunits. Neuropharmacology 38:635644.
  • Diaz E. (2010) Regulation of AMPA receptors by transmembrane accessory proteins. Eur J Neurosci 32:261268.
  • Dimpfel W, Chatterjee SS, Noldner M, Ticku MK. (1995) Effects of the anticonvulsant losigamone and its isomers on the GABAA receptor system. Epilepsia 36:983989.
  • Ding YX, Zhang Y, He B, Yue WH, Zhang D, Zou LP. (2010) A possible association of responsiveness to adrenocorticotropic hormone with specific GRIN1 haplotypes in infantile spasms. Dev Med Child Neurol 52:10281032.
  • Dingledine R, Borges K, Bowie D, Traynelis SF. (1999) The glutamate receptor ion channels. Pharmacol Rev 51:761.
  • Draguhn A, Jungclaus M, Sokolowa S, Heinemann U. (1997) Losigamone decreases spontaneous synaptic activity in cultured hippocampal neurons. Eur J Pharmacol 325:245251.
  • Ekonomou A, Smith AL, Angelatou F. (2001) Changes in AMPA receptor binding and subunit messenger RNA expression in hippocampus and cortex in the pentylenetetrazole-induced ‘kindling’ model of epilepsy. Brain Res Mol Brain Res 95:2735.
  • El Bahh B, Balosso S, Hamilton T, Herzog H, Beck-Sickinger AG, Sperk G, Gehlert DR, Vezzani A, Colmers WF. (2005) The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors. Eur J Neurosci 22:14171430.
  • Endele S, Rosenberger G, Geider K, Popp B, Tamer C, Stefanova I, Milh M, Kortum F, Fritsch A, Pientka FK, Hellenbroich Y, Kalscheuer VM, Kohlhase J, Moog U, Rappold G, Rauch A, Ropers HH, von Spiczak S, Tonnies H, Villeneuve N, Villard L, Zabel B, Zenker M, Laube B, Reis A, Wieczorek D, Van Maldergem L, Kutsche K. (2010) Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat Genet 42:10211026.
  • Epelbaum J, Dournaud P, Fodor M, Viollet C. (1994) The neurobiology of somatostatin. Crit Rev Neurobiol 8:2544.
  • Erickson JC, Clegg KE, Palmiter RD. (1996) Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381:415421.
  • Ernfors P, Bengzon J, Kokaia Z, Persson H, Lindvall O. (1991) Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis. Neuron 7:165176.
  • Etholm L, Linden H, Eken T, Heggelund P. (2011) Electroencephalographic characterization of seizure activity in the synapsin I/II double knockout mouse. Brain Res 1383:270288.
  • Etholm L, Bahonjic E, Walaas SI, Kao HT, Heggelund P. (2012) Neuroethologically delineated differences in the seizure behavior of Synapsin 1 and Synapsin 2 knock-out mice. Epilepsy Res 99:252259.
  • Faire K, Trent F, Tepper JM, Bonder EM. (1992) Analysis of dynamin isoforms in mammalian brain: dynamin-1 expression is spatially and temporally regulated during postnatal development. Proc Natl Acad Sci U S A 89:83768380.
  • Farisello P, Boido D, Nieus T, Medrihan L, Cesca F, Valtorta F, Baldelli P, Benfenati F. (2012) Synaptic and extrasynaptic origin of the excitation/inhibition imbalance in the hippocampus of synapsin I/II/III knockout mice. Cereb Cortex Feb 24:[Epub ahead of print].
  • Fassio A, Patry L, Congia S, Onofri F, Piton A, Gauthier J, Pozzi D, Messa M, Defranchi E, Fadda M, Corradi A, Baldelli P, Lapointe L, St-Onge J, Meloche C, Mottron L, Valtorta F, Khoa Nguyen D, Rouleau GA, Benfenati F, Cossette P. (2011) SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function. Hum Mol Genet 20:22972307.
  • Ferguson SM, De Camilli P. (2012) Dynamin, a membrane-remodelling GTPase. Nat Rev Mol Cell Biol 13:7588.
  • Ferguson SM, Brasnjo G, Hayashi M, Wolfel M, Collesi C, Giovedi S, Raimondi A, Gong LW, Ariel P, Paradise S, O’Toole E, Flavell R, Cremona O, Miesenbock G, Ryan TA, De Camilli P. (2007) A selective activity-dependent requirement for dynamin 1 in synaptic vesicle endocytosis. Science 316:570574.
  • Ferraguti F, Shigemoto R. (2006) Metabotropic glutamate receptors. Cell Tissue Res 326:483504.
  • Ferraguti F, Crepaldi L, Nicoletti F. (2008) Metabotropic glutamate 1 receptor: current concepts and perspectives. Pharmacol Rev 60:536581.
  • Fetissov SO, Kopp J, Hokfelt T. (2004) Distribution of NPY receptors in the hypothalamus. Neuropeptides 38:175188.
  • Figueiredo TH, Qashu F, Apland JP, Aroniadou-Anderjaska V, Souza AP, Braga MF. (2011) The GluK1 (GluR5) Kainate/{alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist LY293558 reduces soman-induced seizures and neuropathology. J Pharmacol Exp Ther 336:303312.
  • Fisher JL, Mott DD. (2011) Distinct functional roles of subunits within the heteromeric kainate receptor. J Neurosci 31:1711317122.
  • Floren A, Sollenberg U, Lundstrom L, Zorko M, Stojan J, Budihna M, Wheatley M, Martin NP, Kilk K, Mazarati A, Bartfai T, Lindgren M, Langel U. (2005) Multiple interaction sites of galnon trigger its biological effects. Neuropeptides 39:547558.
  • Forrest D, Yuzaki M, Soares HD, Ng L, Luk DC, Sheng M, Stewart CL, Morgan JI, Connor JA, Curran T. (1994) Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death. Neuron 13:325338.
  • Fukaya M, Yamazaki M, Sakimura K, Watanabe M. (2005) Spatial diversity in gene expression for VDCCgamma subunit family in developing and adult mouse brains. Neurosci Res 53:376383.
  • Furtinger S, Pirker S, Czech T, Baumgartner C, Ransmayr G, Sperk G. (2001) Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy. J Neurosci 21:58045812.
  • Galanopoulou AS, Buckmaster PS, Staley KJ, Moshe SL, Perucca E, Engel J Jr, Loscher W, Noebels JL, Pitkanen A, Stables J, White HS, O’Brien TJ, Simonato M. (2012) Identification of new epilepsy treatments: issues in preclinical methodology. Epilepsia 53:571582.
  • Garcia CC, Blair HJ, Seager M, Coulthard A, Tennant S, Buddles M, Curtis A, Goodship JA. (2004) Identification of a mutation in synapsin I, a synaptic vesicle protein, in a family with epilepsy. J Med Genet 41:183186.
  • Garske GE, Palmer GC, Napier JJ, Griffith RC, Freedman LR, Harris EW, Ray R, McCreedy SA, Blosser JC, Woodhead JH, White S, Swinyard EA. (1991) Preclinical profile of the anticonvulsant remacemide and its enantiomers in the rat. Epilepsy Res 9:161174.
  • Gehlert DR. (1994) Subtypes of receptors for neuropeptide Y: implications for the targeting of therapeutics. Life Sci 55:551562.
  • Gottsch ML, Zeng H, Hohmann JG, Weinshenker D, Clifton DK, Steiner RA. (2005) Phenotypic analysis of mice deficient in the type 2 galanin receptor (GALR2). Mol Cell Biol 25:48044811.
  • Goussakov IV, Fink K, Elger CE, Beck H. (2000) Metaplasticity of mossy fiber synaptic transmission involves altered release probability. J Neurosci 20:34343441.
  • Govindaiah G, Cox CL. (2006) Metabotropic glutamate receptors differentially regulate GABAergic inhibition in thalamus. J Neurosci 26:1344313453.
  • Gulyas AI, Hajos N, Katona I, Freund TF. (2003) Interneurons are the local targets of hippocampal inhibitory cells which project to the medial septum. Eur J Neurosci 17:18611872.
  • Guo H, Castro PA, Palmiter RD, Baraban SC. (2002) Y5 receptors mediate neuropeptide Y actions at excitatory synapses in area CA3 of the mouse hippocampus. J Neurophysiol 87:558566.
  • Hanada T, Hashizume Y, Tokuhara N, Takenaka O, Kohmura N, Ogasawara A, Hatakeyama S, Ohgoh M, Ueno M, Nishizawa Y. (2011) Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy. Epilepsia 52:13311340.
  • Heine M. (2012) Surface traffic in synaptic membranes. Adv Exp Med Biol 970:197219.
  • Heinrich C, Lahteinen S, Suzuki F, Anne-Marie L, Huber S, Haussler U, Haas C, Larmet Y, Castren E, Depaulis A. (2011) Increase in BDNF-mediated TrkB signaling promotes epileptogenesis in a mouse model of mesial temporal lobe epilepsy. Neurobiol Dis 42:3547.
  • Hilfiker S, Benfenati F, Doussau F, Nairn AC, Czernik AJ, Augustine GJ, Greengard P. (2005) Structural domains involved in the regulation of transmitter release by synapsins. J Neurosci 25:26582669.
  • Hofer M, Pagliusi SR, Hohn A, Leibrock J, Barde YA. (1990) Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J 9:24592464.
  • Horak M, Wenthold RJ. (2009) Different roles of C-terminal cassettes in the trafficking of full-length NR1 subunits to the cell surface. J Biol Chem 284:96839691.
  • Hughes SW, Cope DW, Blethyn KL, Crunelli V. (2002) Cellular mechanisms of the slow (<1 Hz) oscillation in thalamocortical neurons in vitro. Neuron 33:947958.
  • Humpel C, Wetmore C, Olson L. (1993) Regulation of brain-derived neurotrophic factor messenger RNA and protein at the cellular level in pentylenetetrazol-induced epileptic seizures. Neuroscience 53:909918.
  • Inamura M, Itakura M, Okamoto H, Hoka S, Mizoguchi A, Fukazawa Y, Shigemoto R, Yamamori S, Takahashi M. (2006) Differential localization and regulation of stargazin-like protein, gamma-8 and stargazin in the plasma membrane of hippocampal and cortical neurons. Neurosci Res 55:4553.
  • Isackson PJ, Huntsman MM, Murray KD, Gall CM. (1991) BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: temporal patterns of induction distinct from NGF. Neuron 6:937948.
  • Jackson AC, Nicoll RA. (2011) The expanding social network of ionotropic glutamate receptors: TARPs and other transmembrane auxiliary subunits. Neuron 70:178199.
  • Jane DE, Lodge D, Collingridge GL. (2009) Kainate receptors: pharmacology, function and therapeutic potential. Neuropharmacology 56:90113.
  • Janz R, Sudhof TC. (1999) SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family. Neuroscience 94:12791290.
  • Janz R, Goda Y, Geppert M, Missler M, Sudhof TC. (1999) SV2A and SV2B function as redundant Ca2 +  regulators in neurotransmitter release. Neuron 24:10031016.
  • Jovanovska V, Krishnasamy N, Powell K, Bland R, During MJ, O’Brien TJ, Morris MJ. (2011) Gene therapy for idiopathic generalised epilepsy: viral-vector mediated NPY overexpression in ventrolateral thalamus suppresses absence-like seizures in a genetic rat mode. Australian and New Zealand Association of Neurologists Annual Scientific Meeting, Hobart, Australia.
  • Kalashnikova E, Lorca RA, Kaur I, Barisone GA, Li B, Ishimaru T, Trimmer JS, Mohapatra DP, Diaz E. (2010) SynDIG1: an activity-regulated, AMPA- receptor-interacting transmembrane protein that regulates excitatory synapse development. Neuron 65:8093.
  • Kaminski RM, Matagne A, Patsalos PN, Klitgaard H. (2009) Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam. Epilepsia 50:387397.
  • Kammermeier PJ, Worley PF. (2007) Homer 1a uncouples metabotropic glutamate receptor 5 from postsynaptic effectors. Proc Natl Acad Sci U S A 104:60556060.
  • Kaplan DR, Miller FD. (2000) Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10:381391.
  • Kato A, Ozawa F, Saitoh Y, Hirai K, Inokuchi K. (1997) vesl, a gene encoding VASP/Ena family related protein, is upregulated during seizure, long-term potentiation and synaptogenesis. FEBS Lett 412:183189.
  • Kato AS, Gill MB, Ho MT, Yu H, Tu Y, Siuda ER, Wang H, Qian YW, Nisenbaum ES, Tomita S, Bredt DS. (2010) Hippocampal AMPA receptor gating controlled by both TARP and cornichon proteins. Neuron 68:10821096.
  • Kennard JT, Barmanray R, Sampurno S, Ozturk E, Reid CA, Paradiso L, D’Abaco GM, Kaye AH, Foote SJ, O’Brien TJ, Powell KL. (2011) Stargazin and AMPA receptor membrane expression is increased in the somatosensory cortex of genetic absence epilepsy rats from Strasbourg. Neurobiol Dis 42:4854.
  • Kielland A, Erisir A, Walaas SI, Heggelund P. (2006) Synapsin utilization differs among functional classes of synapses on thalamocortical cells. J Neurosci 26:57865793.
  • Kim JH, Huganir RL. (1999) Organization and regulation of proteins at synapses. Curr Opin Cell Biol 11:248254.
  • Klugmann M, Symes CW, Leichtlein CB, Klaussner BK, Dunning J, Fong D, Young D, During MJ. (2005) AAV-mediated hippocampal expression of short and long Homer 1 proteins differentially affect cognition and seizure activity in adult rats. Mol Cell Neurosci 28:347360.
  • Kobayashi M, Buckmaster PS. (2003) Reduced inhibition of dentate granule cells in a model of temporal lobe epilepsy. J Neurosci 23:24402452.
  • Koch D, Spiwoks-Becker I, Sabanov V, Sinning A, Dugladze T, Stellmacher A, Ahuja R, Grimm J, Schuler S, Muller A, Angenstein F, Ahmed T, Diesler A, Moser M, Tom Dieck S, Spessert R, Boeckers TM, Fassler R, Hubner CA, Balschun D, Gloveli T, Kessels MM, Qualmann B. (2011) Proper synaptic vesicle formation and neuronal network activity critically rely on syndapin I. EMBO J 30:49554969.
  • Kofler N, Kirchmair E, Schwarzer C, Sperk G. (1997) Altered expression of NPY-Y1 receptors in kainic acid induced epilepsy in rats. Neurosci Lett 230:129132.
  • Kogo N, Dalezios Y, Capogna M, Ferraguti F, Shigemoto R, Somogyi P. (2004) Depression of GABAergic input to identified hippocampal neurons by group III metabotropic glutamate receptors in the rat. Eur J Neurosci 19:27272740.
  • Krauss GL, Bar M, Biton V, Klapper JA, Rektor I, Vaiciene-Magistris N, Squillacote D, Kumar D. (2012) Tolerability and safety of perampanel: two randomized dose-escalation studies. Acta Neurol Scand 125:815.
  • Krestel HE, Shimshek DR, Jensen V, Nevian T, Kim J, Geng Y, Bast T, Depaulis A, Schonig K, Schwenk F, Bujard H, Hvalby O, Sprengel R, Seeburg PH. (2004) A genetic switch for epilepsy in adult mice. J Neurosci 24:1056810578.
  • Lakhan R, Kalita J, Misra UK, Kumari R, Mittal B. (2010) Association of intronic polymorphism rs3773364 A>G in synapsin-2 gene with idiopathic epilepsy. Synapse 64:403408.
  • Letts VA, Felix R, Biddlecome GH, Arikkath J, Mahaffey CL, Valenzuela A, Bartlett FS II, Mori Y, Campbell KP, Frankel WN. (1998) The mouse stargazer gene encodes a neuronal Ca2 + -channel gamma subunit. Nat Genet 19:340347.
  • Liang F, Le LD, Jones EG. (1998) Reciprocal up- and down-regulation of BDNF mRNA in tetanus toxin-induced epileptic focus and inhibitory surround in cerebral cortex. Cereb Cortex 8:481491.
  • Lindner D, Stichel J, Beck-Sickinger AG. (2008) Molecular recognition of the NPY hormone family by their receptors. Nutrition 24:907917.
  • Lo BW, Kyu HH, Jichici D, Upton AM, Akl EA, Meade MO. (2011) Meta-analysis of randomized trials on first line and adjunctive levetiracetam. Can J Neurol Sci 38:475486.
  • Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B. (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A 101:98619866.
  • Marksteiner J, Sperk G, Maas D. (1989) Differential increases in brain levels of neuropeptide Y and vasoactive intestinal polypeptide after kainic acid-induced seizures in the rat. Naunyn Schmiedebergs Arch Pharmacol 339:173177.
  • Marsh DJ, Baraban SC, Hollopeter G, Palmiter RD. (1999) Role of the Y5 neuropeptide Y receptor in limbic seizures. Proc Natl Acad Sci U S A 96:1351813523.
  • Matagne A, Margineanu DG, Potschka H, Loscher W, Michel P, Kenda B, Klitgaard H. (2009) Profile of the new pyrrolidone derivative seletracetam (ucb 44212) in animal models of epilepsy. Eur J Pharmacol 614:3037.
  • Mathern GW, Pretorius JK, Leite JP, Kornblum HI, Mendoza D, Lozada A, Bertram EH III. (1998) Hippocampal AMPA and NMDA mRNA levels and subunit immunoreactivity in human temporal lobe epilepsy patients and a rodent model of chronic mesial limbic epilepsy. Epilepsy Res 32:154171.
  • Mazarati A, Lu X. (2005) Regulation of limbic status epilepticus by hippocampal galanin type 1 and type 2 receptors. Neuropeptides 39:277280.
  • Mazarati AM, Hohmann JG, Bacon A, Liu H, Sankar R, Steiner RA, Wynick D, Wasterlain CG. (2000) Modulation of hippocampal excitability and seizures by galanin. J Neurosci 20:62766281.
  • Mazarati A, Lu X, Kilk K, Langel U, Wasterlain C, Bartfai T. (2004) Galanin type 2 receptors regulate neuronal survival, susceptibility to seizures and seizure-induced neurogenesis in the dentate gyrus. Eur J Neurosci 19:32353244.
  • Mazarati A, Lundstrom L, Sollenberg U, Shin D, Langel U, Sankar R. (2006) Regulation of kindling epileptogenesis by hippocampal galanin type 1 and type 2 receptors: the effects of subtype-selective agonists and the role of G-protein-mediated signaling. J Pharmacol Exp Ther 318:700708.
  • McColl CD, Jacoby AS, Shine J, Iismaa TP, Bekkers JM. (2006) Galanin receptor-1 knockout mice exhibit spontaneous epilepsy, abnormal EEGs and altered inhibition in the hippocampus. Neuropharmacology 50:209218.
  • McNamara JO, Huang YZ, Leonard AS. (2006) Molecular signaling mechanisms underlying epileptogenesis. Sci STKE 2006:re12.
  • Meeren HK, Pijn JP, Van Luijtelaar EL, Coenen AM, Lopes da Silva FH. (2002) Cortical focus drives widespread corticothalamic networks during spontaneous absence seizures in rats. J Neurosci 22:14801495.
  • Meldrum BS, Rogawski MA. (2007) Molecular targets for antiepileptic drug development. Neurotherapeutics 4:1861.
  • Merten N, Beck-Sickinger AG. (2006) Molecular ligand-receptor interaction of the NPY/PP peptide family. EXS 95:3562.
  • Messa M, Congia S, Defranchi E, Valtorta F, Fassio A, Onofri F, Benfenati F. (2010) Tyrosine phosphorylation of synapsin I by Src regulates synaptic-vesicle trafficking. J Cell Sci 123:22562265.
  • Messaoudi E, Bardsen K, Srebro B, Bramham CR. (1998) Acute intrahippocampal infusion of BDNF induces lasting potentiation of synaptic transmission in the rat dentate gyrus. J Neurophysiol 79:496499.
  • Meurs A, Clinckers R, Ebinger G, Michotte Y, Smolders I. (2007) Clinical potential of neuropeptide Y receptor ligands in the treatment of epilepsy. Curr Top Med Chem 7:16601674.
  • Mineff EM, Weinberg RJ. (2000) Differential synaptic distribution of AMPA receptor subunits in the ventral posterior and reticular thalamic nuclei of the rat. Neuroscience 101:969982.
  • Mitsukawa K, Lu X, Bartfai T. (2010) Galanin, galanin receptors, and drug targets. EXS 102:723.
  • Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH. (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12:529540.
  • Morris MJ, Gannan E, Stroud LM, Beck-Sickinger AG, O’Brien TJ. (2007) Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors. Eur J Neurosci 25:11361143.
  • Mosbacher J, Schoepfer R, Monyer H, Burnashev N, Seeburg PH, Ruppersberg JP. (1994) A molecular determinant for submillisecond desensitization in glutamate receptors. Science 266:10591062.
  • Moschovos C, Kostopoulos G, Papatheodoropoulos C. (2012) Endogenous adenosine induces NMDA receptor-independent persistent epileptiform discharges in dorsal and ventral hippocampus via activation of A2 receptors. Epilepsy Res 100:157167.
  • Ngomba RT, Santolini I, Biagioni F, Molinaro G, Simonyi A, van Rijn CM, D’Amore V, Mastroiacovo F, Olivieri G, Gradini R, Ferraguti F, Battaglia G, Bruno V, Puliti A, van Luijtelaar G, Nicoletti F. (2011) Protective role for type-1 metabotropic glutamate receptors against spike and wave discharges in the WAG/Rij rat model of absence epilepsy. Neuropharmacology 60:12811291.
  • Nibuya M, Morinobu S, Duman RS. (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:75397547.
  • Noe F, Pool AH, Nissinen J, Gobbi M, Bland R, Rizzi M, Balducci C, Ferraguti F, Sperk G, During MJ, Pitkanen A, Vezzani A. (2008) Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy. Brain 131:15061515.
  • Noe F, Frasca A, Balducci C, Carli M, Sperk G, Ferraguti F, Pitkanen A, Bland R, Fitzsimons H, During M, Vezzani A. (2009) Neuropeptide Y overexpression using recombinant adeno-associated viral vectors. Neurotherapeutics 6:300306.
  • Norris SK, King AE. (1997) Electrophysiological effects of the anticonvulsant remacemide hydrochloride and its metabolite ARL 12495AA on rat CA1 hippocampal neurons in vitro. Neuropharmacology 36:951959.
  • Obay BD, Tasdemir E, Tumer C, Bilgin HM, Sermet A. (2007) Antiepileptic effects of ghrelin on pentylenetetrazole-induced seizures in rats. Peptides 28:12141219.
  • Ortiz AA, Milardo LF, DeCarr LB, Buckholz TM, Mays MR, Claus TH, Livingston JN, Mahle CD, Lumb KJ. (2007) A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents. J Pharmacol Exp Ther 323:692700.
  • Palmer GC, Stagnitto ML, Ordy JM, Griffith RC, Napier JJ, Gentile RJ, Woodhead JH, White HS, Swinyard EA. (1991) Preclinical profile of stereoisomers of the anticonvulsant remacemide in mice. Epilepsy Res 8:3648.
  • Patel YC. (1999) Somatostatin and its receptor family. Front Neuroendocrinol 20:157198.
  • Pedrazzini T, Pralong F, Grouzmann E. (2003) Neuropeptide Y: the universal soldier. Cell Mol Life Sci 60:350377.
  • Pellock JM. (1999) Felbamate in epilepsy therapy: evaluating the risks. Drug Saf 21:225239.
  • Perez-Otano I, Ehlers MD. (2005) Homeostatic plasticity and NMDA receptor trafficking. Trends Neurosci 28:229238.
  • Portelli J, Michotte Y, Smolders I. (2012) Ghrelin: an emerging new anticonvulsant neuropeptide. Epilepsia 53:585595.
  • Potschka H, Krupp E, Ebert U, Gumbel C, Leichtlein C, Lorch B, Pickert A, Kramps S, Young K, Grune U, Keller A, Welschof M, Vogt G, Xiao B, Worley PF, Loscher W, Hiemisch H. (2002) Kindling-induced overexpression of Homer 1A and its functional implications for epileptogenesis. Eur J Neurosci 16:21572165.
  • Poulsen FR, Jahnsen H, Blaabjerg M, Zimmer J. (2002) Pilocarpine-induced seizure-like activity with increased BNDF and neuropeptide Y expression in organotypic hippocampal slice cultures. Brain Res 950:103118.
  • Powell KL, Kyi M, Reid CA, Paradiso L, D’Abaco GM, Kaye AH, Foote SJ, O’Brien TJ. (2008) Genetic absence epilepsy rats from Strasbourg have increased corticothalamic expression of stargazin. Neurobiol Dis 31:261265.
  • Priel A, Kolleker A, Ayalon G, Gillor M, Osten P, Stern-Bach Y. (2005) Stargazin reduces desensitization and slows deactivation of the AMPA-type glutamate receptors. J Neurosci 25:26822686.
  • Prince HK, Conn PJ, Blackstone CD, Huganir RL, Levey AI. (1995) Down-regulation of AMPA receptor subunit GluR2 in amygdaloid kindling. J Neurochem 64:462465.
  • Prince HC, Tzingounis AV, Levey AI, Conn PJ. (2000) Functional downregulation of GluR2 in piriform cortex of kindled animals. Synapse 38:489498.
  • Qualmann B, Kelly RB. (2000) Syndapin isoforms participate in receptor-mediated endocytosis and actin organization. J Cell Biol 148:10471062.
  • Qualmann B, Roos J, DiGregorio PJ, Kelly RB. (1999) Syndapin I, a synaptic dynamin-binding protein that associates with the neural Wiskott-Aldrich syndrome protein. Mol Biol Cell 10:501513.
  • Raimondi A, Ferguson SM, Lou X, Armbruster M, Paradise S, Giovedi S, Messa M, Kono N, Takasaki J, Cappello V, O’Toole E, Ryan TA, De Camilli P. (2011) Overlapping role of dynamin isoforms in synaptic vesicle endocytosis. Neuron 70:11001114.
  • Rajasekaran K, Todorovic M, Kapur J. (2012) Calcium-permeable AMPA receptors are expressed in a rodent model of status epilepticus. Ann Neurol 72:91102.
  • Ramachandran R. (2011) Vesicle scission: dynamin. Semin Cell Dev Biol 22:1017.
  • Reibel S, Nadi S, Benmaamar R, Larmet Y, Carnahan J, Marescaux C, Depaulis A. (2001) Neuropeptide Y and epilepsy: varying effects according to seizure type and receptor activation. Peptides 22:529539.
  • Richichi C, Lin EJ, Stefanin D, Colella D, Ravizza T, Grignaschi G, Veglianese P, Sperk G, During MJ, Vezzani A. (2004) Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. J Neurosci 24:30513059.
  • Rodriguez-Moreno A, Lerma J. (1998) Kainate receptor modulation of GABA release involves a metabotropic function. Neuron 20:12111218.
  • Rogawski MA. (2011) Revisiting AMPA receptors as an antiepileptic drug target. Epilepsy Curr 11:5663.
  • Saar K, Mazarati AM, Mahlapuu R, Hallnemo G, Soomets U, Kilk K, Hellberg S, Pooga M, Tolf BR, Shi TS, Hokfelt T, Wasterlain C, Bartfai T, Langel U. (2002) Anticonvulsant activity of a nonpeptide galanin receptor agonist. Proc Natl Acad Sci U S A 99:71367141.
  • Sachdeo R, Kramer LD, Rosenberg A, Sachdeo S. (1992) Felbamate monotherapy: controlled trial in patients with partial onset seizures. Ann Neurol 32:386392.
  • Sakagami Y, Yamamoto K, Sugiura S, Inokuchi K, Hayashi T, Kato N. (2005) Essential roles of Homer-1a in homeostatic regulation of pyramidal cell excitability: a possible link to clinical benefits of electroconvulsive shock. Eur J Neurosci 21:32293239.
  • Salt TE, Eaton SA. (1995) Modulation of sensory neurone excitatory and inhibitory responses in the ventrobasal thalamus by activation of metabotropic excitatory amino acid receptors. Neuropharmacology 34:10431051.
  • Salt TE, Turner JP. (1998) Modulation of sensory inhibition in the ventrobasal thalamus via activation of group II metabotropic glutamate receptors by 2R,4R-aminopyrrolidine-2,4-dicarboxylate. Exp Brain Res 121:181185.
  • Sanchez RM, Koh S, Rio C, Wang C, Lamperti ED, Sharma D, Corfas G, Jensen FE. (2001) Decreased glutamate receptor 2 expression and enhanced epileptogenesis in immature rat hippocampus after perinatal hypoxia-induced seizures. J Neurosci 21:81548163.
  • Schmidt-Kastner R, Humpel C, Wetmore C, Olson L. (1996) Cellular hybridization for BDNF, trkB, and NGF mRNAs and BDNF-immunoreactivity in rat forebrain after pilocarpine-induced status epilepticus. Exp Brain Res 107:331347.
  • Schneider BM, Dodman NH, Faissler D, Ogata N. (2009) Clinical use of an herbal-derived compound (Huperzine A) to treat putative complex partial seizures in a dog. Epilepsy Behav 15:529534.
  • Schwenk J, Harmel N, Zolles G, Bildl W, Kulik A, Heimrich B, Chisaka O, Jonas P, Schulte U, Fakler B, Klocker N. (2009) Functional proteomics identify cornichon proteins as auxiliary subunits of AMPA receptors. Science 323:13131319.
  • Seeburg PH, Hartner J. (2003) Regulation of ion channel/neurotransmitter receptor function by RNA editing. Curr Opin Neurobiol 13:279283.
  • Selcher JC, Xu W, Hanson JE, Malenka RC, Madison DV. (2012) Glutamate receptor subunit GluA1 is necessary for long-term potentiation and synapse unsilencing, but not long-term depression in mouse hippocampus. Brain Res 1435:814.
  • Sheldon AL, Robinson MB. (2007) The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int 51:333355.
  • Shin DM, Dehoff M, Luo X, Kang SH, Tu J, Nayak SK, Ross EM, Worley PF, Muallem S. (2003) Homer 2 tunes G protein-coupled receptors stimulus intensity by regulating RGS proteins and PLCbeta GAP activities. J Cell Biol 162:293303.
  • Sofia RD. (1994) Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and gamma-aminobutyric acidA receptors. Ann Neurol 36:677678.
  • Sommer B, Kohler M, Sprengel R, Seeburg PH. (1991) RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67:1119.
  • Sorensen AT, Nikitidou L, Ledri M, Lin EJ, During MJ, Kanter-Schlifke I, Kokaia M. (2009) Hippocampal NPY gene transfer attenuates seizures without affecting epilepsy-induced impairment of LTP. Exp Neurol 215:328333.
  • Srinivasan J, Richens A, Davies JA. (1997) The effect of losigamone (AO-33) on electrical activity and excitatory amino acid release in mouse cortical slices. Br J Pharmacol 122:14901494.
  • Srivastava S, Osten P, Vilim FS, Khatri L, Inman G, States B, Daly C, DeSouza S, Abagyan R, Valtschanoff JG, Weinberg RJ, Ziff EB. (1998) Novel anchorage of GluR2/3 to the postsynaptic density by the AMPA receptor-binding protein ABP. Neuron 21:581591.
  • Stansfield KH, Pilsner JR, Lu Q, Wright RO, Guilarte TR. (2012) Dysregulation of BDNF-TrkB signaling in developing hippocampal neurons by Pb(2 + ): implications for an environmental basis of neurodevelopmental disorders. Toxicol Sci 127:277295.
  • Streit AK, Derst C, Wegner S, Heinemann U, Zahn RK, Decher N. (2011) RNA editing of Kv1.1 channels may account for reduced ictogenic potential of 4-aminopyridine in chronic epileptic rats. Epilepsia 52:645648.
  • Stroud LM, O’Brien TJ, Jupp B, Wallengren C, Morris MJ. (2005) Neuropeptide Y suppresses absence seizures in a genetic rat model. Brain Res 1033:151156.
  • Subramaniam S, Donevan SD, Rogawski MA. (1996) Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite. J Pharmacol Exp Ther 276:161168.
  • Tanaka H, Grooms SY, Bennett MV, Zukin RS. (2000) The AMPAR subunit GluR2: still front and center-stage. Brain Res 886:190207.
  • Tomioka R, Okamoto K, Furuta T, Fujiyama F, Iwasato T, Yanagawa Y, Obata K, Kaneko T, Tamamaki N. (2005) Demonstration of long-range GABAergic connections distributed throughout the mouse neocortex. Eur J Neurosci 21:15871600.
  • Tomita S, Chen L, Kawasaki Y, Petralia RS, Wenthold RJ, Nicoll RA, Bredt DS. (2003) Functional studies and distribution define a family of transmembrane AMPA receptor regulatory proteins. J Cell Biol 161:805816.
  • Tomita S, Fukata M, Nicoll RA, Bredt DS. (2004) Dynamic interaction of stargazin-like TARPs with cycling AMPA receptors at synapses. Science 303:15081511.
  • Tomita S, Stein V, Stocker TJ, Nicoll RA, Bredt DS. (2005) Bidirectional synaptic plasticity regulated by phosphorylation of stargazin-like TARPs. Neuron 45:269277.
  • Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R. (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62:405496.
  • Tu B, Timofeeva O, Jiao Y, Nadler JV. (2005) Spontaneous release of neuropeptide Y tonically inhibits recurrent mossy fiber synaptic transmission in epileptic brain. J Neurosci 25:17181729.
  • Turnbull J, Lohi H, Kearney JA, Rouleau GA, Delgado-Escueta AV, Meisler MH, Cossette P, Minassian BA. (2005) Sacred disease secrets revealed: the genetics of human epilepsy. Hum Mol Genet 14(No. 2):24912500.
  • Turner JP, Salt TE. (1998) Characterization of sensory and corticothalamic excitatory inputs to rat thalamocortical neurones in vitro. J Physiol 510(Pt 3):829843.
  • Turner JP, Salt TE. (2000) Synaptic activation of the group I metabotropic glutamate receptor mGlu1 on the thalamocortical neurons of the rat dorsal lateral geniculate nucleus in vitro. Neuroscience 100:493505.
  • Turner JP, Salt TE. (2003) Group II and III metabotropic glutamate receptors and the control of the nucleus reticularis thalami input to rat thalamocortical neurones in vitro. Neuroscience 122:459469.
  • Upreti C, Otero R, Partida C, Skinner F, Thakker R, Pacheco LF, Zhou ZY, Maglakelidze G, Veliskova J, Velisek L, Romanovicz D, Jones T, Stanton PK, Garrido-Sanabria ER. (2012) Altered neurotransmitter release, vesicle recycling and presynaptic structure in the pilocarpine model of temporal lobe epilepsy. Brain 135:869885.
  • van Raay L, Jovanovska V, Morris MJ, O’Brien TJ. (2012) Focal administration of neuropeptide Y into the S2 somatosensory cortex maximally suppresses absence seizures in a genetic rat model. Epilepsia 53:477484.
  • van Vliet EA, Aronica E, Redeker S, Boer K, Gorter JA. (2009) Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy. Epilepsia 50:422433.
  • Ved HS, Koenig ML, Dave JR, Doctor BP. (1997) Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate. NeuroReport 8:963968.
  • Vezzani A, Schwarzer C, Lothman EW, Williamson J, Sperk G. (1996) Functional changes in somatostatin and neuropeptide Y containing neurons in the rat hippocampus in chronic models of limbic seizures. Epilepsy Res 26:267279.
  • Vezzani A, Sperk G, Colmers WF. (1999) Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci 22:2530.
  • Vezzani A, Moneta D, Mule F, Ravizza T, Gobbi M, French-Mullen J. (2000) Plastic changes in neuropeptide Y receptor subtypes in experimental models of limbic seizures. Epilepsia 41(Suppl. 6):S115S121.
  • Viollet C, Lepousez G, Loudes C, Videau C, Simon A, Epelbaum J. (2008) Somatostatinergic systems in brain: networks and functions. Mol Cell Endocrinol 286:7587.
  • Vogl C, Mochida S, Wolff C, Whalley BJ, Stephens GJ. (2012) The synaptic vesicle glycoprotein 2A ligand levetiracetam inhibits presynaptic Ca2 +  channels through an intracellular pathway. Mol Pharmacol 82:199208.
  • Vollmar W, Gloger J, Berger E, Kortenbruck G, Kohling R, Speckmann EJ, Musshoff U. (2004) RNA editing (R/G site) and flip-flop splicing of the AMPA receptor subunit GluR2 in nervous tissue of epilepsy patients. Neurobiol Dis 15:371379.
  • von Engelhardt J, Mack V, Sprengel R, Kavenstock N, Li KW, Stern-Bach Y, Smit AB, Seeburg PH, Monyer H. (2010) CKAMP44: a brain-specific protein attenuating short-term synaptic plasticity in the dentate gyrus. Science 327:15181522.
  • von Rosenstiel P. (2007) Brivaracetam (UCB 34714). Neurotherapeutics 4:8487.
  • Walther C, Morl K, Beck-Sickinger AG. (2011) Neuropeptide Y receptors: ligand binding and trafficking suggest novel approaches in drug development. J Pept Sci 17:233246.
  • Wan QF, Zhou ZY, Thakur P, Vila A, Sherry DM, Janz R, Heidelberger R. (2010) SV2 acts via presynaptic calcium to regulate neurotransmitter release. Neuron 66:884895.
  • Wang FJ, Li CM, Hou XH, Wang XR, Zhang LM. (2011) Selective upregulation of brain-derived neurotrophic factor (BDNF) transcripts and BDNF direct induction of activity independent N-methyl-D-aspartate currents in temporal lobe epilepsy patients with hippocampal sclerosis. J Int Med Res 39:13581368.
  • Wesnes KA, Edgar C, Dean AD, Wroe SJ. (2009) The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy. Epilepsy Behav 14:522528.
  • Wetmore C, Ernfors P, Persson H, Olson L. (1990) Localization of brain-derived neurotrophic factor mRNA to neurons in the brain by in situ hybridization. Exp Neurol 109:141152.
  • White HS, Scholl EA, Klein BD, Flynn SP, Pruess TH, Green BR, Zhang L, Bulaj G. (2009) Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models. Neurotherapeutics 6:372380.
  • Wiater MF, Mukherjee S, Li AJ, Dinh TT, Rooney EM, Simasko SM, Ritter S. (2011) Circadian integration of sleep-wake and feeding requires NPY receptor-expressing neurons in the mediobasal hypothalamus. Am J Physiol Regul Integr Comp Physiol 301:R1569R1583.
  • Widdowson PS. (1993) Quantitative receptor autoradiography demonstrates a differential distribution of neuropeptide-Y Y1 and Y2 receptor subtypes in human and rat brain. Brain Res 631:2738.
  • Wu JT, Kral JG. (2004) Ghrelin: integrative neuroendocrine peptide in health and disease. Ann Surg 239:464474.
  • Wu G, Feder A, Wegener G, Bailey C, Saxena S, Charney D, Mathe AA. (2011) Central functions of neuropeptide Y in mood and anxiety disorders. Expert Opin Ther Targets 15:13171331.
  • Xia J, Zhang X, Staudinger J, Huganir RL. (1999) Clustering of AMPA receptors by the synaptic PDZ domain-containing protein PICK1. Neuron 22:179187.
  • Yao J, Bajjalieh SM. (2008) Synaptic vesicle protein 2 binds adenine nucleotides. J Biol Chem 283:2062820634.
  • Yao J, Nowack A, Kensel-Hammes P, Gardner RG, Bajjalieh SM. (2010) Cotrafficking of SV2 and synaptotagmin at the synapse. J Neurosci 30:55695578.
  • Zafra F, Hengerer B, Leibrock J, Thoenen H, Lindholm D. (1990) Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non-NMDA glutamate receptors. EMBO J 9:35453550.
  • Zhang YH, Zhao XY, Chen XQ, Wang Y, Yang HH, Hu GY. (2002) Spermidine antagonizes the inhibitory effect of huperzine A on [3H]dizocilpine (MK-801) binding in synaptic membrane of rat cerebral cortex. Neurosci Lett 319:107110.
  • Ziff EB. (2007) TARPs and the AMPA receptor trafficking paradox. Neuron 53:627633.
  • Zini S, Roisin MP, Langel U, Bartfai T, Ben-Ari Y. (1993) Galanin reduces release of endogenous excitatory amino acids in the rat hippocampus. Eur J Pharmacol 245:17.